68 related articles for article (PubMed ID: 35368152)
1. Intestinal virome in patients with alcohol use disorder and after abstinence.
Hsu CL; Zhang X; Jiang L; Lang S; Hartmann P; Pride D; Fouts DE; Stärkel P; Schnabl B
Hepatol Commun; 2022 Aug; 6(8):2058-2069. PubMed ID: 35368152
[TBL] [Abstract][Full Text] [Related]
2. Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome.
Hsu CL; Lang S; Demir M; Fouts DE; Stärkel P; Schnabl B
Hepatology; 2023 Jun; 77(6):2073-2083. PubMed ID: 36631002
[TBL] [Abstract][Full Text] [Related]
3. Multi-Omics Analyses Show Disease, Diet, and Transcriptome Interactions With the Virome.
Mihindukulasuriya KA; Mars RAT; Johnson AJ; Ward T; Priya S; Lekatz HR; Kalari KR; Droit L; Zheng T; Blekhman R; D'Amato M; Farrugia G; Knights D; Handley SA; Kashyap PC
Gastroenterology; 2021 Oct; 161(4):1194-1207.e8. PubMed ID: 34245762
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder.
Hartmann P; Lang S; Zeng S; Duan Y; Zhang X; Wang Y; Bondareva M; Kruglov A; Fouts DE; Stärkel P; Schnabl B
Front Physiol; 2021; 12():699253. PubMed ID: 34349667
[TBL] [Abstract][Full Text] [Related]
5. Enteric Phageome Alterations in Patients With Type 2 Diabetes.
Chen Q; Ma X; Li C; Shen Y; Zhu W; Zhang Y; Guo X; Zhou J; Liu C
Front Cell Infect Microbiol; 2020; 10():575084. PubMed ID: 33552999
[TBL] [Abstract][Full Text] [Related]
6. The virome in allergy and asthma: A nascent, ineffable player.
Mageiros L; Megremis S; Papadopoulos NG
J Allergy Clin Immunol; 2023 Dec; 152(6):1347-1351. PubMed ID: 37778473
[TBL] [Abstract][Full Text] [Related]
7. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation.
Thiele Orberg E; Meedt E; Hiergeist A; Xue J; Heinrich P; Ru J; Ghimire S; Miltiadous O; Lindner S; Tiefgraber M; Göldel S; Eismann T; Schwarz A; Göttert S; Jarosch S; Steiger K; Schulz C; Gigl M; Fischer JC; Janssen KP; Quante M; Heidegger S; Herhaus P; Verbeek M; Ruland J; van den Brink MRM; Weber D; Edinger M; Wolff D; Busch DH; Kleigrewe K; Herr W; Bassermann F; Gessner A; Deng L; Holler E; Poeck H
Nat Cancer; 2024 Jan; 5(1):187-208. PubMed ID: 38172339
[TBL] [Abstract][Full Text] [Related]
8. Phages in the Human Body.
Navarro F; Muniesa M
Front Microbiol; 2017; 8():566. PubMed ID: 28421059
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome in alcohol use disorder: Implications for health outcomes and therapeutic strategies-a literature review.
Koutromanos I; Legaki E; Gazouli M; Vasilopoulos E; Kouzoupis A; Tzavellas E
World J Methodol; 2024 Mar; 14(1):88519. PubMed ID: 38577203
[TBL] [Abstract][Full Text] [Related]
10. The role of the microbiome in liver disease.
Schöler D; Schnabl B
Curr Opin Gastroenterol; 2024 May; 40(3):134-142. PubMed ID: 38362864
[TBL] [Abstract][Full Text] [Related]
11. Structural changes in the gut virome of patients with atherosclerotic cardiovascular disease.
Li Y; Ma J; Meng J; Li S; Zhang Y; You W; Sai X; Yang J; Zhang S; Sun W
Microbiol Spectr; 2024 Jan; 12(1):e0105023. PubMed ID: 38051048
[TBL] [Abstract][Full Text] [Related]
12. Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases.
Fujiki J; Schnabl B
JHEP Rep; 2023 Dec; 5(12):100909. PubMed ID: 37965159
[TBL] [Abstract][Full Text] [Related]
13. Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles.
Aghara H; Chadha P; Zala D; Mandal P
Front Immunol; 2023; 14():1205821. PubMed ID: 37841267
[TBL] [Abstract][Full Text] [Related]
14. Alcohol-associated bowel disease: new insights into pathogenesis.
Maccioni L; Fu Y; Horsmans Y; Leclercq I; Stärkel P; Kunos G; Gao B
eGastroenterology; 2023 Jun; 1(1):. PubMed ID: 37662449
[TBL] [Abstract][Full Text] [Related]
15. The Novel Role of Phage Particles in Chronic Liver Diseases.
Chen L; Hou X; Chu H
Microorganisms; 2023 Apr; 11(5):. PubMed ID: 37317156
[TBL] [Abstract][Full Text] [Related]
16. The gut-liver axis and gut microbiota in health and liver disease.
Hsu CL; Schnabl B
Nat Rev Microbiol; 2023 Nov; 21(11):719-733. PubMed ID: 37316582
[TBL] [Abstract][Full Text] [Related]
17. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure.
Hartmann P; Lang S; Schierwagen R; Klein S; Praktiknjo M; Trebicka J; Schnabl B
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):474-481. PubMed ID: 37198098
[TBL] [Abstract][Full Text] [Related]
18. Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review.
Odriozola A; Santos-Laso A; Del Barrio M; Cabezas J; Iruzubieta P; Arias-Loste MT; Rivas C; Duque JCR; Antón Á; Fábrega E; Crespo J
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175497
[TBL] [Abstract][Full Text] [Related]
19. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.
Kaufmann B; Seyfried N; Hartmann D; Hartmann P
Am J Physiol Gastrointest Liver Physiol; 2023 Jul; 325(1):G42-G61. PubMed ID: 37129252
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
